PolarityTE Competitors, Revenue, Alternatives and Pricing
Estimated Revenue & Financials
- PolarityTE's estimated annual revenue is currently $1.6M per year.
- PolarityTE received $17.8M in venture funding in September 2017.
- PolarityTE's estimated revenue per employee is $16,281
- PolarityTE's total funding is $17.8M.
- PolarityTE has 96 Employees.
- PolarityTE grew their employee count by -36% last year.
- PolarityTE currently has 4 job openings.
|Competitor Name||Revenue||Number of Employees||Employee Growth||Total Funding||Online Review||Pricing|
What Is PolarityTE?
PolarityTE (NASDAQ: COOL) is a commercial-stage biotechnology and regenerative biomaterials company focused on transforming the lives of patients by discovering, designing and developing a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering and material sciences. The PolarityTE platform technology begins with a small piece of the patient's own, or autologous, healthy tissue, rather than artificially manipulated individual cells. From this small piece of healthy autologous tissue, the company creates an easily deployable, dynamic and self-propagating product designed to enhance and stimulate the patient's own cells to regenerate the target tissues. Rather than manufacturing with synthetic and foreign materials within artificially engineered environments, PolarityTE manufactures with the patient's own tissue and uses the patient's own body to support the regenerative process to create the same tissue from which it was derived. PolarityTE's innovative method is intended to promote and accelerate growth of the patient's tissues to undergo a form of effective regenerative healing.keywords:N/A
Number of Employees
Employee Growth %
SALT LAKE CITY, Sept. 9, 2019 /PRNewswire/ -- PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing and commercializing ...
SALT LAKE CITY, Aug. 16, 2019 /PRNewswire/ -- PolarityTE, Inc. (NASDAQ: PTE), a biotechnology company developing and commercializing ...
SALT LAKE CITY, Aug. 28, 2019 /PRNewswire/ -- PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing and commercializing ...
|Company Name||Revenue||Number of Employees||Employee Growth||Total Funding||Online Review||Pricing|
PolarityTE Executive Hires
|2017-03-01||Burke Powers||Vice President of Product Development||Article|
|2017-10-09||Maurice Nahabedian||Chief Surgical Officer||Article|
|2018-09-27||Alain Adam||Vice President, Sales||Article|
|2018-10-22||Sharon Whalen||Vice President of Market Access||Article|
|2018-11-28||Matt Kemp||Chief Commercial Officer||Article|
|2019-01-08||Jon Burrows||Pres Contract Services/SVP Corporate Development||Article|
|2019-01-30||David Seaburg||President of Corporate Development||Article|